Semaglutide improves brain-related injury patients’ outcomes
GLP-1R agonist semaglutide, also known as Ozempic or Wegovy, has been making headlines for its potential in its original market…
GLP-1R agonist semaglutide, also known as Ozempic or Wegovy, has been making headlines for its potential in its original market…
Alebund Pharmaceuticals has announced positive topline Phase III results highlighting that the use of AP301 has demonstrated a statistically significant…
Seasonal epidemics of respiratory syncytial virus (RSV) have a significant health burden in children in the UK. RSV is spread…
The World Health Organization (WHO) has announced new guidelines for human immunodeficiency virus (HIV) prevention and management that will reshape…
According to the US Centers for Disease Control and Prevention (CDC), a third of US teenagers are prediabetic, meaning that…
World Brain Day, celebrated annually on 22 July, serves as a call to action for increased neurological health awareness and…
This month, the Journal of the American Medical Association (JAMA) published a collaborative article between the Children’s Hospital of Philadelphia…
Plastic additives such as phthalates and bisphenols help to enhance the functionality of plastic materials. These endocrine-disrupting chemicals (EDCs) are…
In May 2025, the World Health Organization (WHO) published its landmark initiative to address the lack of equity in clinical…
According to the World Health Organization, autism spectrum disorder (ASD) affects approximately 10% of children globally. ASD is theorised to…